{
    "Trade/Device Name(s)": [
        "AG-6081 Single Blood Glucose Monitoring System",
        "AG-6951 Single Blood Glucose Monitoring System",
        "AG-6081 MULTI Blood Glucose Monitoring System",
        "AG-6951 MULTI Blood Glucose Monitoring System",
        "AGS-1100 Control Solution"
    ],
    "Submitter Information": "Andon Medical Co., Ltd.",
    "510(k) Number": "K101307",
    "Predicate Device Reference 510(k) Number(s)": [
        "K073030"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JX"
    ],
    "Summary Letter Date": "July 25, 2011",
    "Summary Letter Received Date": "July 28, 2011",
    "Submission Date": "May 9, 2010",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "AG-6081 Single Blood Glucose Meter",
        "AG-6951 Single Blood Glucose Meter",
        "AG-6081 MULTI Blood Glucose Meter",
        "AG-6951 MULTI Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometry",
        "Electrochemical biosensor",
        "Glucose oxidase enzymatic reaction"
    ],
    "Methodologies": [
        "Electrochemical measurement"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "System",
        "Reagent",
        "Control",
        "Test Strip"
    ],
    "Document Summary": "FDA 510(k) summary for Andon Medical Co., Ltd. blood glucose monitoring systems using amperometric electrochemical biosensor technology for quantitative measurement of glucose in capillary whole blood.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from fingertip, palm, forearm, upper arm, calf and thigh for self-testing (single models) or multiple-patient use in professional healthcare settings (MULTI models) as an aid to monitor diabetes control; not for diagnosis or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}